HCM
MIRM icon

Hollencrest Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Hollencrest Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,888
Closed -$149K – 1267
2025
Q4 		$149K Hold
1,888
– – 0.01% 387
2025
Q3 		$138K Buy
+1,888
New +$120K 0.01% 376

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Hollencrest Capital Management's MIRM Position: Q1 2026 in Review

Hollencrest Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 1,888 shares — an estimated $149K sold.

Hollencrest Capital Management first reported a position in MIRM in Q3 2025 and held it in 2 quarters. The position peaked at $149K in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Hollencrest Capital Management reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Hollencrest Capital Management sold 1,888 Mirum Pharmaceuticals shares in Q1 2026, an estimated $149K.
  • Hollencrest Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Hollencrest Capital Management's Mirum Pharmaceuticals position peaked at $149K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Hollencrest Capital Management's 13F filing for Q1 2026, filed 7 May 2026.